NCT06730022View on ClinicalTrials.gov

Dermacyte® Liquid for Treatment of Cutaneous Ulcers and Wounds

AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

Not specified

Conditions
Cutaneous UlcerDiabetic UlcerSurgical Wound DehiscenceBurns - MultiplePressure UlcersMixed UlcerIschemic Ulcer
Interventions
DRUG

MTX-001 (Dermacyte Liquid)

Repeat dose subcutaneous drug injection for the treatment of serious chronic wounds.

Trial Locations (1)

80004

AVAILABLE

The WISH Clinic, Arvada

Sponsors
All Listed Sponsors
lead

Merakris Therapeutics

INDUSTRY

NCT06730022 - Dermacyte® Liquid for Treatment of Cutaneous Ulcers and Wounds | Biotech Hunter | Biotech Hunter